Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 17/20 | 0.62 |
| ▸ | PLK3 | Q9H4B4 | 8/20 | 0.62 |
| ▸ | IKBKE | Q14164 | 3/20 | 0.62 |
| ▸ | CDK2 | P24941 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3259200 | 1.00 | PLK1 (0.62) | PLK1PLK3IKBKECDK2CYP2C9 | |
| SCHEMBL3614266 | 0.93 | PLK1 (0.63) | PLK1PLK3IKBKECDK2CYP2C9 | |
| SCHEMBL13440042 | 0.90 | PLK1 (0.52) | PLK1PLK3IKBKECDK2 | |
| SCHEMBL3252779 | 0.90 | PLK1 (0.49) | PLK1PLK3IKBKECDK2CYP2C9 | |
| SCHEMBL3267734 | 0.90 | PLK1 (0.49) | PLK1PLK3IKBKECDK2CYP2C9 | |
| SCHEMBL3259164 | 0.90 | PLK1 (0.52) | PLK1PLK3IKBKECDK2 | |
| SCHEMBL3255726 | 0.89 | PLK1 (0.63) | PLK1PLK3IKBKECDK2 | |
| SCHEMBL13440023 | 0.88 | PLK1 (0.51) | PLK1PLK3IKBKECDK2 | |
| SCHEMBL3253745 | 0.88 | PLK1 (0.51) | PLK1PLK3IKBKECDK2 | |
| SCHEMBL3256389 | 0.88 | PLK1 (0.47) | PLK1PLK3IKBKECDK2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615643-B2 | 3-[((1R)-1-{2-Chloro-3-[(1-methyl-4-piperidinyl)oxy]phenyl}ethyl)oxy]-5-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]-2-thiophenecarboxamide; polo like kinase enzyme inhibitors; anticarcinogenic agents for treating cancer | SMITHKLINE BEECHAM CORPORATION (US) | 2009-11-10 | — | — | US | disclosed |